abstract |
The present invention is a compound of formula (I) Embedded image It relates to novel azetidine compounds of formula (I) in which R 1 , R 2 and X are as described in the description, and their use as orexin receptor antagonists. These compounds may be used in particular in the treatment of cognitive dysfunction, for example in eating disorders, drinking disorders, sleep disorders, or psychiatric and neurological disorders. |